# GLAND share price, delivery % and history — Gland Pharma Limited

> Delivery percentage for Gland Pharma Limited (GLAND) against its own history, with 1,452 sessions of split-adjusted NSE data from 2020 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/GLAND

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 2,899.4 INR (-3.02% on the day), 2026-09-30
- Delivery: 45.44% of volume taken to demat (20-day average 52.97%)
- Volume: 5.29L shares, turnover ₹153.2Cr
- Relative volume: 0.82× of its own 20-day average

## Technicals

- RSI(14): 51.31
- ATR(14): 87.59
- SMA 50: 2,795.01, SMA 200: 2,142.25
- 52-week range: 1,573.6 – 3,042 (-4.69% from the high)

## Performance

- 1 week -0.37%, 1 month 0.47%, 3 months 18.53%
- 6 months 68.17%, 1 year 43.73%

## Delivery percentage

- Latest: 45.44% (2026-09-30)
- 20-day average: 52.97%
- 1-year average: 53.8%
- Percentile against its own history: 30th
- Range: 8.51% – 94.71% across 1,448 sessions with a reading

Over the last 20 sessions GLAND settled 53.0% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 53.8%. The latest session ranks higher than 30% of the 1,448 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 47,843.2 crore
- P/E (TTM): 42.38 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 68.41 INR, split-adjusted to match the price series
- Revenue growth: 19.57% YoY, 3.3% QoQ
- Profit growth: 47.09% YoY, -13.56% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 7.15% | 25.03% |
| 3y | 19.14% | 14.81% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 1,405.8 | 1,208.7 | 256.8 | 163.5 | 9.93 | 11.63% |
| 2024-12-31 | 1,384.1 | 1,143.2 | 299.3 | 204.7 | 12.42 | 14.79% |
| 2025-03-31 | 1,424.9 | 1,180.6 | 288.3 | 186.5 | 11.32 | 13.09% |
| 2025-06-30 | 1,505.6 | 1,250.4 | 312.7 | 215.5 | 13.08 | 14.31% |
| 2025-09-30 | 1,486.9 | 1,287.1 | 283.9 | 183.7 | 11.15 | 12.35% |
| 2025-12-31 | 1,695.4 | 1,372.1 | 362.1 | 261.5 | 15.87 | 15.42% |
| 2026-03-31 | 1,742.8 | 1,348.5 | 505.8 | 366.7 | 22.26 | 21.04% |
| 2026-06-30 | 1,800.3 | 1,426.5 | 435 | 317 | 19.23 | 17.61% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 51.77%
- Public: 48.23%
- FII: 8.74%, DII: 30.44%
- Promoter shares pledged: 0%

## Recent filings

- 2026-08-11: dividend
- 2026-08-10: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_184555_10082026171916_iXBRL_WEB.html
- 2026-07-20: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697195_20072026055314_WEB.xml
- 2026-05-15: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_158184_15052026210920_iXBRL_WEB.html
- 2026-04-17: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1653191_17042026041011_WEB.xml
- 2026-01-28: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_138587_29012026180909_iXBRL_WEB.html
- 2026-01-16: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1602551_16012026052655_WEB.xml
- 2025-11-03: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_124231_03112025211237_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 46 events are indexed for this instrument.

## About the instrument

- Listed: 2020-11-20 — latest session 2026-09-30 (1,452 sessions)
- ISIN: INE068V01023
- Series: EQ
- Liquidity rank: #145 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)
- [CIPLA](https://patternsradar.com/s/CIPLA.md) — Cipla Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/GLAND.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.